Cargando…
Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in middle eastern families
BACKGROUND: Identification of genes responsible for medically important traits is a major challenge in human genetics. Due to the genetic heterogeneity of hearing loss, targeted DNA capture and massively parallel sequencing are ideal tools to address this challenge. Our subjects for genome analysis...
Autores principales: | Brownstein, Zippora, Friedman, Lilach M, Shahin, Hashem, Oron-Karni, Varda, Kol, Nitzan, Rayyan, Amal Abu, Parzefall, Thomas, Lev, Dorit, Shalev, Stavit, Frydman, Moshe, Davidov, Bella, Shohat, Mordechai, Rahile, Michele, Lieberman, Sari, Levy-Lahad, Ephrat, Lee, Ming K, Shomron, Noam, King, Mary-Claire, Walsh, Tom, Kanaan, Moien, Avraham, Karen B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308052/ https://www.ncbi.nlm.nih.gov/pubmed/21917145 http://dx.doi.org/10.1186/gb-2011-12-9-r89 |
Ejemplares similares
-
Israeli Position Paper: Triage Decisions for Severely Ill Patients During the COVID-19 Pandemic
por: Steinberg, Avraham, et al.
Publicado: (2020) -
Helicase-inactivating BRIP1 mutation yields Fanconi anemia with microcephaly and other congenital abnormalities
por: Kamal, Lara, et al.
Publicado: (2020) -
Prenatal Isolated Ventricular Septal Defect May Not Be Associated with Trisomy 21
por: Shen, Ori, et al.
Publicado: (2014) -
Israeli Position Paper: Triage Decisions for Severely Ill Patients During the COVID-19 Pandemic. Joint Commission of the Israel National Bioethics Council, the Ethics Bureau of the Israel Medical Association and Representatives from the Israeli Ministry of Health
por: Steinberg, Avraham, et al.
Publicado: (2020) -
To Be (Vaccinated) or Not to Be: The Effect of Media Exposure, Institutional Trust, and Incentives on Attitudes toward COVID-19 Vaccination
por: Zimand-Sheiner, Dorit, et al.
Publicado: (2021)